Matthew Smith
Matthew Smith @Smithmr88

Performance
All

2.04%2026
2026
21.34%2025
2025
13.70%2024
2024
5.16%2023
2023
-13.26%2022
2022
-5.89%2021
2021
12.22%2020
2020
21.3%0%-21.3%
Discussions
Matthew Smith
Matthew Smith
United Kingdom
4y
It continues to be a tough start to the year. I have taken the time to rebalance the portfolio and have been slowly building up a strong dividend portfolio. The current market provides and excellent buying opportunity for strong dividend stocks. Main additions have been $DLG.L $HON (Honeywell International... Show More
Matthew Smith
Matthew Smith shared a post via Matthew Smith
United Kingdom
4y
I closed this trade at a gain of 10.30% on 02/02/2022 May re-buy closer to 45
Matthew Smith
Matthew Smith
closed a $INMD buy position
United Kingdom
4y
INMD
Inmode Ltd
10.30%
Trade Story
Matthew Smith
Matthew Smith
United Kingdom
5y
$UK100 A break above the resistance line and I think we can see back over 7500.
Not investment advice. The author may have financial interests in the mentioned instruments.
Matthew Smith
Matthew Smith
United Kingdom
5y
$NSDQ100 Looks like it may have either bounced off of its 1D 100MA and be going back up or it's going to break through and head to around 12700. Will have to wait for a clear sign either way.
Not investment advice. The author may have financial interests in the mentioned instruments.
undefined logo
NSDQ100
29024.82
0.30 (0.00%)
Matthew Smith
Matthew Smith
United Kingdom
5y
$VST (Vistra Corp) Even accounting for a potentially large hit this year from a one time charge from the recent storm in Texas, I still see this stock as being heavily undervalued long term. Whilst the exact amount is unknown, they also don't plan to lie back and may look to take their suppliers... Show More
undefined logo
VST
Vistra Corp
146.78
-0.09 (-0.06%)
Matthew Smith
Matthew Smith
United Kingdom
5y
$VRTX (Vertex Pharmaceuticals Incorporated) I have recently done a DCF for Vertex and believe they have strong growth potential. I have upgraded my target for the stock to $346.7 within the next 12-18 months.
Not investment advice. The author may have financial interests in the mentioned instruments.
undefined logo
VRTX
Vertex Pharmaceuticals Incorporated
442.50
-5.79 (-1.29%)
Matthew Smith
Matthew Smith
United Kingdom
5y
$ISF.L (iShares Core FTSE 100 UCITS ETF (Dist)) We appear to be in a symmetrical triangle pattern. A breakout, and I see us heading towards 711. A breakdown and we could be heading back towards 580. $UK100
Not investment advice. The author may have financial interests in the mentioned instruments.
Matthew Smith
Matthew Smith
United Kingdom
5y
Edited
I have had several issues over the past few days with opening/closing positions as well as untriggered stop losses causing greater losses and affecting my risk score due to these losses. Combined with the recent login issues I expect a full and thorough investigation into why by eToro. I have lodged... Show More
Matthew Smith
Matthew Smith
United Kingdom
5y
$NSDQ100 Looks like it's down and down. We have broken through the trend line and I believe we will be heading down to the 100 day MA. I can see the region of 12600-12700.
Not investment advice. The author may have financial interests in the mentioned instruments.
Matthew Smith
Matthew Smith
United Kingdom
5y
$NSDQ100 Are we looking at a pullback to 13525 region, or even 13000? What are your thoughts?
Not investment advice. The author may have financial interests in the mentioned instruments.
undefined logo
NSDQ100
29024.82
0.30 (0.00%)

About Matthew Smith
United Kingdom

Experience: St Andrews University, MA(Hons) Management then worked in London for an IFA. Masters from University of Aberdeen; MSc Economics and Portfolio Management. I then discovered the world of wine and after working for Hilton in F&B Management I am now a Sommelier. I have been investing for 13... Show More
2 Copiers
186 Followers

Similar Traders